Phio Pharmaceuticals Corp.（PHIO）内部人交易：高管与董事近期交易
过去 18 个月，共有 8 位内部人为 Phio Pharmaceuticals Corp.（PHIO）报告了 38 笔 Form 4 交易（最近一笔 2026-09-30）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-30 | Plott Ronald Todd | 董事 | 买入 | 5,000 | $5,150 |
| 2026-09-30 | Plott Ronald Todd | 董事 | 买入 | 5,000 | $5,200 |
| 2026-09-29 | Bitterman Robert J | Chairman, Pres. & CEO | 买入 | 400,000 | $0 |
| 2026-09-29 | Plott Ronald Todd | 董事 | 买入 | 17,000 | $0 |
| 2026-09-29 | Carson Lisa Cabott | Chief Financial Officer | 买入 | 108,000 | $0 |
| 2026-09-25 | BRADFORD PATRICIA A | 董事 | 买入 | 6,500 | $6,583 |
| 2026-09-23 | Bitterman Robert J | Chairman, Pres. & CEO | 买入 | 2,000 | $2,058 |
| 2026-09-16 | BRADFORD PATRICIA A | 董事 | 买入 | 12,000 | $12,360 |
| 2026-09-15 | Bitterman Robert J | Chairman, Pres. & CEO | 卖出 | 68,550 | $70,606 |
| 2026-09-15 | Carson Lisa Cabott | Chief Financial Officer | 卖出 | 12,888 | $13,275 |
| 2026-08-20 | Plott Ronald Todd | 董事 | 买入 | 15,000 | $17,100 |
| 2026-08-19 | Bitterman Robert J | Chairman, Pres. & CEO | 买入 | 10,000 | $10,600 |
| 2026-06-29 | Bitterman Robert J | Chairman, Pres. & CEO | 买入 | 10,000 | $9,900 |
| 2026-02-06 | BRADFORD PATRICIA A | 董事 | 买入 | 18,500 | $0 |
| 2026-02-06 | Freeman Jonathan E | 董事 | 买入 | 16,600 | $0 |
| 2026-02-06 | Carson Lisa Cabott | Chief Financial Officer | 买入 | 47,000 | $0 |
| 2026-02-06 | Lockshin Curtis | 董事 | 买入 | 16,600 | $0 |
| 2026-02-06 | Bitterman Robert J | Chairman, Pres. & CEO | 买入 | 120,000 | $0 |
| 2026-02-06 | Deming David H | 董事 | 买入 | 23,800 | $0 |
| 2026-01-02 | Bitterman Robert J | Chairman, Pres. & CEO | 买入 | 5,000 | $5,150 |
| 2025-12-29 | Bitterman Robert J | Chairman, Pres. & CEO | 买入 | 5,000 | $5,100 |
| 2025-11-24 | Bitterman Robert J | Chairman, Pres. & CEO | 买入 | 5,000 | $5,700 |
| 2025-11-19 | Bitterman Robert J | Chairman, Pres. & CEO | 买入 | 5,000 | $6,350 |
| 2025-09-15 | Carson Lisa Cabott | VP, Finance and Administration | 买入 | 47,000 | $0 |
| 2025-09-15 | Freeman Jonathan E | 董事 | 买入 | 14,700 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-30